Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HylaCare for Radiation Dermatitis in Breast Cancer
NCT02165605Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2012
- Primary completion
- Nov 2015
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Randomised, double-blind trial in radiation dermatitis comparing HylaCare Side with Placebo Side (2 arms). Primary endpoints: Acute Skin Toxicity Per NCI-CTC v4.0 at 5 weeks and Acute Skin Toxicity Per Investigator Grading Scale at 5 weeks. Started Aug 2012; status: completed.
02
Drugs
HylaCare
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT02165605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165605.